Pathogenetic role of eNOS uncoupling in cardiopulmonary disorders

被引:109
作者
Gielis, Jan F. [2 ]
Lin, Judy Y. [1 ]
Wingler, Kirstin [3 ]
Van Schil, Paul E. Y. [2 ]
Schmidt, Harald H. [3 ]
Moens, An L. [1 ]
机构
[1] Maastricht Univ Med Ctr, Dept Cardiol, Cardiovasc Res Inst Maastricht, NL-6202 AZ Maastricht, Netherlands
[2] Univ Antwerp, Dept Vasc & Thorac Surg, B-2020 Antwerp, Belgium
[3] Maastricht Univ Med Ctr, Dept Pharmacol, Cardiovasc Res Inst Maastricht, NL-6202 AZ Maastricht, Netherlands
基金
澳大利亚国家健康与医学研究理事会;
关键词
eNOS uncoupling; Superoxide; Tetrahydrobiopterin; eNOS modulators; Cardioprotection; Free radicals; NITRIC-OXIDE SYNTHASE; ENDOTHELIUM-DEPENDENT VASODILATION; VASCULAR SUPEROXIDE-PRODUCTION; GTP CYCLOHYDROLASE-I; L-ARGININE; FOLIC-ACID; MYOCARDIAL-INFARCTION; REPERFUSION INJURY; OXIDATIVE STRESS; TRANSGENIC MICE;
D O I
10.1016/j.freeradbiomed.2010.12.018
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The homodimeric flavohemeprotein endothelial nitric oxide synthase (eNOS) oxidizes L-arginine to L-citrulline and nitric oxide (NO), which acutely vasodilates blood vessels and inhibits platelet aggregation. Chronically, eNOS has a major role in the regulation of blood pressure and prevention of atherosclerosis by decreasing leukocyte adhesion and smooth muscle proliferation. However, a disturbed vascular redox balance result:; in eNOS damage and uncoupling of oxygen activation from L-arginine conversion. Uncoupled eNOS monomerizes and generates reactive oxygen species (ROS) rather than NO. Indeed, eNOS uncoupling has been suggested as one of the main pathomechanisms in a broad range of cardiovascular and pulmonary disorders such as atherosclerosis, ventricular remodeling, and pulmonary hypertension. Therefore, modulating uncoupled eNOS, in particular eNOS-dependent ROS generation, is an attractive therapeutic approach to preventing and/or treating cardiopulmonary disorders, including protective effects during cardiothoracic surgery. This review provides a comprehensive overview of the pathogenetic role of uncoupled eNOS in both cardiovascular and pulmonary disorders. In addition, the related therapeutic possibilities such as supplementation with the eNOS substrate L-arginine, volatile NO, and direct NO donors as well as eNOS modulators such as the eNOS cofactor tetrahydrobiopterin and folic acid are discussed in detail. (C) 2010 Published by Elsevier Inc.
引用
收藏
页码:765 / 776
页数:12
相关论文
共 146 条
[1]   L-arginine reduces human monocyte adhesion to vascular endothelium and endothelial expression of cell adhesion molecules [J].
Adams, MR ;
Jessup, W ;
Hailstones, D ;
Celermajer, DS .
CIRCULATION, 1997, 95 (03) :662-668
[2]   GCH1 haplotype determines vascular and plasma biopterin availability in coronary artery disease -: Effects on vascular superoxide production and endothelial function [J].
Antoniades, Charalambos ;
Shirodaria, Cheerag ;
Van Assche, Tim ;
Cunnington, Colin ;
Tegeder, Irmgard ;
Loetsch, Joern ;
Guzik, Tomasz J. ;
Leeson, Paul ;
Diesch, Jonathan ;
Tousoulis, Dimitris ;
Stefanadis, Christodoulos ;
Costigan, Michael ;
Woolf, Clifford J. ;
Alp, Nicholas J. ;
Channon, Keith M. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (02) :158-165
[3]   Altered plasma versus vascular biopterins in human atherosclerosis reveal relationships between endothelial nitric oxide synthase coupling, endothelial function, and inflammation [J].
Antoniades, Charalambos ;
Shirodaria, Cheerag ;
Crabtree, Mark ;
Rinze, Ruth ;
Alp, Nicholas ;
Cunnington, Colin ;
Diesch, Jonathan ;
Tousoulis, Dimitris ;
Stefanadis, Christodoulos ;
Leeson, Paul ;
Ratnatunga, Chandi ;
Pillai, Ravi ;
Channon, Keith M. .
CIRCULATION, 2007, 116 (24) :2851-2859
[4]   Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis [J].
Antoniades, Charalambos ;
Shirodaria, Cheerag ;
Leeson, Paul ;
Antonopoulos, Alexios ;
Warrick, Nicholas ;
Van-Assche, Tim ;
Cunnington, Colin ;
Tousoulis, Dimitris ;
Pillai, Ravi ;
Ratnatunga, Chandi ;
Stefanadis, Christodoulos ;
Channon, Keith M. .
EUROPEAN HEART JOURNAL, 2009, 30 (09) :1142-1150
[5]  
ARDREW PJ, 1999, CARDIOVASC RES, V43, P521
[6]   Arginase pathway in human endothelial cells in pathophysiological conditions [J].
Bachetti, T ;
Comini, L ;
Francolini, G ;
Bastianon, D ;
Valetti, B ;
Cadei, M ;
Grigolato, PG ;
Suzuki, H ;
Finazzi, D ;
Albertini, A ;
Curello, S ;
Ferrari, R .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2004, 37 (02) :515-523
[7]   Increase in fasting vascular endothelial function after short-term oral L-arginine is effective when baseline flow-mediated dilation is low: a meta-analysis of randomized controlled trials [J].
Bai, Yongyi ;
Sun, Lan ;
Yang, Tao ;
Sun, Kai ;
Chen, Jingzhou ;
Hui, Rutai .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2009, 89 (01) :77-84
[8]  
Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
[9]   Stoichiometric relationships between endothelial tetrahydrobiopterin, endothelial NO synthase (eNOS) activity, and eNOS coupling in vivo - Insights from transgenic mice with endothelial-targeted GTP cyclohydrolase 1 and eNOS overexpression [J].
Bendall, JK ;
Alp, NJ ;
Warrick, N ;
Cai, SJ ;
Adlam, D ;
Rockett, K ;
Yokoyama, M ;
Kawashima, S ;
Channon, KM .
CIRCULATION RESEARCH, 2005, 97 (09) :864-871
[10]   Tetrahydrobiopterin deficiencies without hyperphenylalaninemia:: Diagnosis and genetics of DOPA-responsive dystonia and sepiapterin reductase deficiency [J].
Blau, N ;
Bonafé, L ;
Thöny, B .
MOLECULAR GENETICS AND METABOLISM, 2001, 74 (1-2) :172-185